Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jan;39(1):31–38. doi: 10.1111/j.1365-2125.1995.tb04406.x

Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

A Patat 1, M C Perault 1, B Vandel 1, N Ulliac 1, I Zieleniuk 1, P Rosenzweig 1
PMCID: PMC1364978  PMID: 7756096

Abstract

1. The possible interaction between a new H1 antihistamine, mizolastine, and lorazepam was assessed in a randomised, double-blind, cross-over, placebo-controlled study involving 16 healthy young male volunteers who received mizolastine 10 mg or placebo once daily for 8 days with a 1 week wash-out interval. The interaction of mizolastine, at steady-state, with a single oral dose of lorazepam or placebo was assessed on days 6 or 8 of each treatment period. 2. Psychomotor performance and cognitive function were evaluated using objective tests (critical flicker fusion threshold, choice reaction time, tapping, arithmetic calculation, body sway) and self-ratings (visual analogue scale, ARCI) before and at 2, 4, 6 and 8 h after dosing. Short-term memory (Sternberg memory scanning immediate free recall of a word list) and long-term memory (delayed free recall and recognition of words and pictures) were assessed before and at 3 h after dosing. Pharmacodynamic interactions were evaluated by repeated measures ANOVA in a 2 x 2 factorial interaction model. 3. Mizolastine, 10 mg once daily, at steady-state, was devoid of sedation and detrimental effect on skilled performance and memory. 4. In contrast, a single 2 mg dose of lorazepam produced marked impairment of psychomotor performance, cognitive functions (significant reduction in flicker fusion threshold, tapping and arithmetic calculation and increase in reaction times and body sway) and subjective sedation from 2 to 8 h after dosing. In addition, lorazepam induced an anterograde amnesia, characterised by a decrease in delayed free recall and recognition, and a deficit in short term memory.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascalone V., Guinebault P., Rouchouse A. Determination of mizolastine, a new antihistaminic drug, in human plasma by liquid-liquid extraction, solid-phase extraction and column-switching techniques in combination with high-performance liquid chromatography. J Chromatogr. 1993 Sep 22;619(2):275–284. doi: 10.1016/0378-4347(93)80117-m. [DOI] [PubMed] [Google Scholar]
  2. Bhatti J. Z., Hindmarch I. The effects of terfenadine with and without alcohol on an aspect of car driving performance. Clin Exp Allergy. 1989 Nov;19(6):609–611. doi: 10.1111/j.1365-2222.1989.tb02754.x. [DOI] [PubMed] [Google Scholar]
  3. Block R. I., Berchou R. Alprazolam and lorazepam effects on memory acquisition and retrieval processes. Pharmacol Biochem Behav. 1984 Feb;20(2):233–241. doi: 10.1016/0091-3057(84)90248-x. [DOI] [PubMed] [Google Scholar]
  4. Bradley C. M., Nicholson A. N. Studies on the central effects of the H1-antagonist, loratadine. Eur J Clin Pharmacol. 1987;32(4):419–421. doi: 10.1007/BF00543979. [DOI] [PubMed] [Google Scholar]
  5. Buschke H., Fuld P. A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974 Nov;24(11):1019–1025. doi: 10.1212/wnl.24.11.1019. [DOI] [PubMed] [Google Scholar]
  6. Curran H. V., Schiwy W., Lader M. Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives. Psychopharmacology (Berl) 1987;92(3):358–364. doi: 10.1007/BF00210844. [DOI] [PubMed] [Google Scholar]
  7. Danjou P., Molinier P., Berlin I., Patat A., Rosenzweig P., Morselli P. L. Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects. Br J Clin Pharmacol. 1992 Oct;34(4):328–331. doi: 10.1111/j.1365-2125.1992.tb05638.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. File S. E., Bond A. J. Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology (Berl) 1979;66(3):309–313. doi: 10.1007/BF00428325. [DOI] [PubMed] [Google Scholar]
  9. Ghoneim M. M., Hinrichs J. V., Mewaldt S. P. Dose-response analysis of the behavioral effects of diazepam: I. Learning and memory. Psychopharmacology (Berl) 1984;82(4):291–295. doi: 10.1007/BF00427672. [DOI] [PubMed] [Google Scholar]
  10. Ghoneim M. M., Mewaldt S. P., Hinrichs J. V. Dose-response analysis of the behavioral effects of diazepam: II. Psychomotor performance, cognition and mood. Psychopharmacology (Berl) 1984;82(4):296–300. doi: 10.1007/BF00427673. [DOI] [PubMed] [Google Scholar]
  11. Greenblatt D. J., Franke K., Shader R. I. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam. J Chromatogr. 1978 Sep 1;146(2):311–320. [PubMed] [Google Scholar]
  12. Griffiths R. R., Evans S. M., Guarino J. J., Roache J. D., Furman W. R., Liebson I., Schwam E. M. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal. J Pharmacol Exp Ther. 1993 Jun;265(3):1163–1174. [PubMed] [Google Scholar]
  13. Gupta S. K., Ellinwood E. H., Nikaido A. M., Heatherly D. G. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. J Pharmacokinet Biopharm. 1990 Apr;18(2):89–102. doi: 10.1007/BF01063553. [DOI] [PubMed] [Google Scholar]
  14. Haertzen C. A. Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI). Psychol Rep. 1966 Feb;18(1):163–194. doi: 10.2466/pr0.1966.18.1.163. [DOI] [PubMed] [Google Scholar]
  15. Hindmarch I., Gudgeon A. C. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol. 1980 Aug;10(2):145–150. doi: 10.1111/j.1365-2125.1980.tb01731.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kapteyn T. S., Bles W., Njiokiktjien C. J., Kodde L., Massen C. H., Mol J. M. Standardization in platform stabilometry being a part of posturography. Agressologie. 1983 Jun;24(7):321–326. [PubMed] [Google Scholar]
  17. Lister R. G., File S. E. The nature of lorazepam-induced amnesia. Psychopharmacology (Berl) 1984;83(2):183–187. doi: 10.1007/BF00429732. [DOI] [PubMed] [Google Scholar]
  18. Martin W. R., Sloan J. W., Sapira J. D., Jasinski D. R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):245–258. doi: 10.1002/cpt1971122part1245. [DOI] [PubMed] [Google Scholar]
  19. Mattila M. J., Aranko K., Kuitunen T. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine. Br J Clin Pharmacol. 1993 Mar;35(3):272–277. doi: 10.1111/j.1365-2125.1993.tb05694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mattila M. J., Mattila M., Konno K. Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine. Eur J Clin Pharmacol. 1986;31(3):291–298. doi: 10.1007/BF00981126. [DOI] [PubMed] [Google Scholar]
  21. Moser L., Hüther K. J., Koch-Weser J., Lundt P. V. Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings. Eur J Clin Pharmacol. 1978 Dec 18;14(6):417–423. doi: 10.1007/BF00716383. [DOI] [PubMed] [Google Scholar]
  22. Paivio A., Yuille J. C., Madigan S. A. Concreteness, imagery, and meaningfulness values for 925 nouns. J Exp Psychol. 1968 Jan;76(1 Suppl):1–25. doi: 10.1037/h0025327. [DOI] [PubMed] [Google Scholar]
  23. Patat A., Foulhoux P. Effect on postural sway of various benzodiazepine tranquillizers. Br J Clin Pharmacol. 1985 Jul;20(1):9–16. doi: 10.1111/j.1365-2125.1985.tb02792.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Patat A., Gram L. F., Dubruc C., Brohier S., Cabanis M. J., Rosenzweig P. Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Int Clin Psychopharmacol. 1994 Summer;9(2):101–108. doi: 10.1097/00004850-199400920-00006. [DOI] [PubMed] [Google Scholar]
  25. Patat A., Klein M. J., Hucher M., Granier J. Acute effects of amitriptyline on human performance and interactions with diazepam. Eur J Clin Pharmacol. 1988;35(6):585–592. doi: 10.1007/BF00637593. [DOI] [PubMed] [Google Scholar]
  26. Pechadre J. C., Beudin P., Eschalier A., Trolese J. F., Rihoux J. P. A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res. 1991 Jul-Aug;19(4):289–295. doi: 10.1177/030006059101900401. [DOI] [PubMed] [Google Scholar]
  27. Pechadre J. C., Vernay D., Trolese J. F., Bloom M., Dupont P., Rihoux J. P. Comparison of the central and peripheral effects of cetirizine and terfenadine. Eur J Clin Pharmacol. 1988;35(3):255–259. doi: 10.1007/BF00558262. [DOI] [PubMed] [Google Scholar]
  28. Preston G. C., Broks P., Traub M., Ward C., Poppleton P., Stahl S. M. Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology (Berl) 1988;95(2):208–215. doi: 10.1007/BF00174511. [DOI] [PubMed] [Google Scholar]
  29. Ramaekers J. G., Uiterwijk M. M., O'Hanlon J. F. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42(4):363–369. doi: 10.1007/BF00280119. [DOI] [PubMed] [Google Scholar]
  30. Rosenzweig P., Thebault J. J., Caplain H., Dubruc C., Bianchetti G., Fuseau E., Morselli P. L. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. Ann Allergy. 1992 Aug;69(2):135–139. [PubMed] [Google Scholar]
  31. Simons F. E. H1-receptor antagonists. Comparative tolerability and safety. Drug Saf. 1994 May;10(5):350–380. doi: 10.2165/00002018-199410050-00002. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES